Jakafi = Novartis It appears that a huge competitor has become...

Jakafi = Novartis
It appears that a huge competitor has become friend.
Why?
We know many of the short comings of Jakafi including safty and limited trial data for GVHD. This goes beyond GVHD
COVID 19
https://www.sciencedirect.com/science/article/pii/S0924857920301862

In my view we have a safe and reliable replacement for Jakafi. Novartis had to become friend or face economic ruin. A head to head trial forced the point home.

As though replacement of Jakafi is not large enough . This goes beyond Jakafi and consideration for same is still to come.

Entresto, Novartis CHFhttps://hotcopper.com.au/posts/47449136/single


The CAR-T treatments on the market—Novartis’
https://hotcopper.com.au/posts/47387975/single

We have the goods
Good luck all